Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Blueprint Medicines Corp (BPMC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 3,769 shares @ $48.06, valued at $181.1k
09/29/2023 4 Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 5,600 shares @ $48.84, valued at $273.5k
Sold 12,102 shares @ $49.93, valued at $604.3k
Sold 400 shares @ $50.5, valued at $20.2k
Sold 6,898 shares @ $50.17, valued at $346.1k
Exercised 18,102 options to buy @ $1.87, valued at $33.9k
Exercised 6,898 options to buy @ $1.87, valued at $12.9k
08/25/2023 8-K Other Events  Interactive Data
08/24/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
06/30/2023 8-K Other Events  Interactive Data
06/07/2023 4 Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 2,307 shares @ $52.06, valued at $120.1k
06/07/2023 4 Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,404 shares @ $52.05, valued at $73.1k
05/25/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "FIRST AMENDMENT TO FINANCING AGREEMENT"
05/10/2023 ARS/A Form ARS/A - Annual Report to Security Holders: [Amend]
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 8-K Quarterly results
03/08/2023 4 Murray Christopher K. (CHIEF TECHNICAL OPERATIONS) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,829 shares @ $45.71, valued at $83.6k
Sold 46 shares @ $44.3, valued at $2k
03/08/2023 4 Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 2,960 shares @ $45.72, valued at $135.3k
Sold 99 shares @ $44.28, valued at $4.4k
03/08/2023 4 Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,885 shares @ $45.72, valued at $86.2k
Sold 63 shares @ $44.36, valued at $2.8k
03/08/2023 4 Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,466 shares @ $45.72, valued at $67k
Sold 48 shares @ $44.77, valued at $2.1k
03/08/2023 4 Lee Philina (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,622 shares @ $45.72, valued at $74.2k
Sold 54 shares @ $44.4, valued at $2.4k
03/08/2023 4 Durso-Bumpus Debra (CHIEF PEOPLE OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 3,084 shares @ $45.71, valued at $141k
Sold 74 shares @ $44.3, valued at $3.3k
03/08/2023 4 Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 736 shares @ $45.72, valued at $33.6k
Sold 25 shares @ $44.78, valued at $1.1k
03/08/2023 4 Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 9,474 shares @ $45.72, valued at $433.2k
Sold 319 shares @ $44.27, valued at $14.1k
03/08/2023 4 McCain Tracey L (EVP AND CHIEF LEGAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 3,216 shares @ $45.72, valued at $147k
Sold 106 shares @ $44.41, valued at $4.7k
03/08/2023 4 Landsittel Michael (CFO) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 2,911 shares @ $45.72, valued at $133.1k
Sold 96 shares @ $44.48, valued at $4.3k
03/08/2023 4 Hurley Ariel (PRINCIPAL ACCOUNTING OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,091 shares @ $45.72, valued at $49.9k
Sold 35 shares @ $44.4, valued at $1.6k
03/08/2023 4 Haviland Kate (CEO) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 6,428 shares @ $45.72, valued at $293.9k
Sold 212 shares @ $44.65, valued at $9.5k
03/03/2023 4 Lee Philina (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 12,500 shares @ $0
Granted 25,000 options to buy @ $43.15, valued at $1.1M
03/03/2023 4 Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 12,500 shares @ $0
Granted 25,000 options to buy @ $43.15, valued at $1.1M
03/03/2023 4 Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 12,500 shares @ $0
Granted 25,000 options to buy @ $43.15, valued at $1.1M
03/03/2023 4 Landsittel Michael (CFO) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 12,500 shares @ $0
Granted 25,000 options to buy @ $43.15, valued at $1.1M
03/03/2023 4 Durso-Bumpus Debra (CHIEF PEOPLE OFFICER) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 12,500 shares @ $0
Granted 25,000 options to buy @ $43.15, valued at $1.1M
03/03/2023 4 Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 15,000 shares @ $0
Granted 30,000 options to buy @ $43.15, valued at $1.3M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy